Health knowledge and news provided by doctors.

Infant Motrin Drops Recalled Due to Potential Contamination

Children's Motrin

Johnson & Johnson’s consumer healthcare unit has issued a recall on about 200,000 bottles of concentrated Motrin drops for infants.

The company is working with US retailers to remove the affected half-ounce bottles of Original Berry flavored drops because during manufacture, some plastic particles – about the size of a poppy seed – were identified. A total of four lots from the company’s plant in Beerse, Belgium were possibly affected.

J&J has determined that the particles originated in a shipment from a third party supplier of ibuprofen, the active ingredient in Motrin drops.

The recalled bottles can be identified by lot numbers: DCB3T01, DDB4R01 and DDB4S01. The UPC Code is 300450524157; Case UPC code is 30300450524158

Follow eMaxHealth on YouTube, Twitter and Facebook.
Please, click to subscribe to our Youtube Channel to be notified about upcoming health and food tips.

The recall is strictly a precaution. It is not known if the product inside the bottle contains the plastic particles and there have been no reports to suggest any have been found. Use of the drops is unlikely to cause adverse medical reactions, but consumers that have the product at home are asked to dispose and call the company at 1-877-414-7709 for a refund.

Adverse events that may be related to the use of this product can be reported to the US Food and Drug Administration’s Med Watch Program. In the meantime you consumers can check other alternatives such as Motrin vs. Advil.

Reference: Motrin, McNeil Consumer Healthcare

Also Read about Painkillers
Painkiller use increases risk of irregular heart rhythm. "If you use painkillers such as ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) or COX-2 inhibitors to treat inflammation, you may be at increased risk of irregular heart rhythm, or atrial fibrillation," reads the story by EmaxHealth reporter Deborah Mitchell.

Chronic Pain Treatments: Many Options, Poor Results. "The state of chronic pain treatments is unsatisfactory, as none of the commonly used approaches adequately eliminate pain or improve function in the majority of chronic pain patients," concludes the story.